Remodulin
- Product NDC
- 66302-114
- 11-digit product format
- 663020114
- Labeler code
- 66302
- Product ID
- 66302-114_143d514e-fdcd-4766-ba47-0a75395e1f84
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- treprostinil
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- United Therapeutics Corporation
- Application
- NDA021272
- Marketing category
- NDA
- Marketing start
- 2023-09-28
- Substance
- TREPROSTINIL
- Active strength
- 8 mg/20mL
- Pharmacologic classes
- Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| RUM6K67ESG | TREPROSTINIL | 81846-19-7 | TREPROSTINIL |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 66302-114-01 | 66302011401 | 1 VIAL in 1 BOX (66302-114-01) / 20 mL in 1 VIAL | 1 vial | 2023-09-28 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Remodulin | United Therapeutics Corporation | 2025-07-18 | HUMAN PRESCRIPTION DRUG LABEL | 33 |